PL2431046T3 - Zastosowanie ekstraktów z liścia oliwnego w farmaceutycznej kompozycji do indukcji angiogenezy i waskulogenezy - Google Patents

Zastosowanie ekstraktów z liścia oliwnego w farmaceutycznej kompozycji do indukcji angiogenezy i waskulogenezy

Info

Publication number
PL2431046T3
PL2431046T3 PL10774593T PL10774593T PL2431046T3 PL 2431046 T3 PL2431046 T3 PL 2431046T3 PL 10774593 T PL10774593 T PL 10774593T PL 10774593 T PL10774593 T PL 10774593T PL 2431046 T3 PL2431046 T3 PL 2431046T3
Authority
PL
Poland
Prior art keywords
vasculogenesis
pharmaceutical composition
olive leaf
leaf extracts
inducing angiogenesis
Prior art date
Application number
PL10774593T
Other languages
English (en)
Inventor
Gómez José Manuel Quesada
Mora Raquel María Santiago
Díaz Antonio Casado
De Castro María Dolores Luque
Original Assignee
Sanidad Y Residencias 21 S A
Servicio Andaluz De Salud
Quesper R&D S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanidad Y Residencias 21 S A, Servicio Andaluz De Salud, Quesper R&D S L filed Critical Sanidad Y Residencias 21 S A
Publication of PL2431046T3 publication Critical patent/PL2431046T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10774593T 2009-05-14 2010-05-14 Zastosowanie ekstraktów z liścia oliwnego w farmaceutycznej kompozycji do indukcji angiogenezy i waskulogenezy PL2431046T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200901296A ES2349976B1 (es) 2009-05-14 2009-05-14 Utilizacion de extractos de hojas de olivo en una composicion farmaceutica para inducir angiogenesis y vasculogenesis.
PCT/ES2010/070327 WO2010130869A1 (es) 2009-05-14 2010-05-14 Utilización de extractos de hojas de olivo en una composición farmacéutica para inducir angiogénesis y vasculogénesis
EP10774593.7A EP2431046B1 (en) 2009-05-14 2010-05-14 Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis

Publications (1)

Publication Number Publication Date
PL2431046T3 true PL2431046T3 (pl) 2015-07-31

Family

ID=43084660

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10774593T PL2431046T3 (pl) 2009-05-14 2010-05-14 Zastosowanie ekstraktów z liścia oliwnego w farmaceutycznej kompozycji do indukcji angiogenezy i waskulogenezy

Country Status (14)

Country Link
US (1) US20120141435A1 (pl)
EP (1) EP2431046B1 (pl)
BR (1) BRPI1007728B1 (pl)
CY (1) CY1116447T1 (pl)
DK (1) DK2431046T3 (pl)
ES (3) ES2349976B1 (pl)
HR (1) HRP20150455T1 (pl)
LT (1) LT2570124T (pl)
MX (1) MX2011011970A (pl)
PL (1) PL2431046T3 (pl)
PT (1) PT2431046E (pl)
RS (1) RS55672B1 (pl)
SI (1) SI2431046T1 (pl)
WO (1) WO2010130869A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2570124B1 (en) * 2010-05-14 2016-11-02 Sanidad Y Residencias 21, S.A. Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
ES2395539B1 (es) * 2011-06-16 2014-01-20 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Uso del aceite de oliva en la prevención y el tratamiento de las enfermedades que cursan con un proceso isquémico
US12551523B2 (en) * 2021-10-05 2026-02-17 Nutrition Act Co., Ltd. HIF-1 activator
CN116920069B (zh) * 2023-07-06 2024-05-17 廊坊康宝汇泰生物技术有限公司 一种中药提取液及其在促进脐带干细胞分泌vegf中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4139196A (en) * 1994-11-07 1996-05-31 William R. Fredrickson Method and composition for antiviral therapy
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6455070B1 (en) * 2001-02-15 2002-09-24 East Park Research, Inc. Composition for treating symptoms of influenza
CN1315479C (zh) * 2001-05-23 2007-05-16 哈姆迪·K·哈姆迪 橄榄苦苷在制备抑制血管生成药物中的用途
US7214392B2 (en) * 2003-02-25 2007-05-08 Bio-Botanica, Inc. Process and composition for inhibiting growth of microorganisms
WO2004093569A1 (en) * 2003-04-21 2004-11-04 Osman Fathi Osman Topical composition on the basis of honey
EP1481669A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
JP2005245346A (ja) * 2004-03-05 2005-09-15 Kazuo Kagami 複合健康補助食品
NZ532666A (en) 2004-04-30 2008-03-28 Ind Res Ltd A method of promoting angiogenesis, or treating a disease or disorder where it is desirable to promote angiogenesis, comprising administering a therapeutically effective amount of an angiogenesis promoting extract of the skin of a citrus fruit to a non-human animal
DE202005007222U1 (de) * 2005-05-06 2005-07-14 Oliveda Network S.L. Zubereitung auf Basis von flüssigem Olivenblattextrakt und Glycerin
US8758838B2 (en) * 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
ES2274721B1 (es) * 2005-11-03 2008-06-01 Laboratorios Belmac, S.A. Nuevo agente terapeutico para el tratamiento de una condicion asociada a la enfermedad vascular periferica.
US20070292463A1 (en) * 2005-12-22 2007-12-20 Donald Spector Compositions and methods comprising energizable particles for health use
JP2008081425A (ja) * 2006-09-27 2008-04-10 Shiseido Co Ltd 内臓脂肪蓄積抑制剤
JP2008273938A (ja) * 2007-03-30 2008-11-13 Shiseido Co Ltd アディポネクチン産生促進剤
CA2629652A1 (en) * 2007-04-24 2008-10-24 Yaojiong Wu Compositions for preventing or treating skin defects and methods of use thereof
WO2010070183A1 (es) * 2008-12-18 2010-06-24 Sanidad Y Residencias 21, S.A.U. Composición farmacéutica que comprende oleuropeina para utilización en la inducción de angiogénesis y vasculogénesis

Also Published As

Publication number Publication date
EP2431046A4 (en) 2013-07-31
ES2349976A1 (es) 2011-01-13
WO2010130869A1 (es) 2010-11-18
PT2431046E (pt) 2015-05-28
LT2570124T (lt) 2017-02-27
CY1116447T1 (el) 2017-02-08
RS55672B1 (sr) 2017-06-30
EP2431046A1 (en) 2012-03-21
ES2613950T3 (es) 2017-05-29
SI2431046T1 (sl) 2015-07-31
HRP20150455T1 (hr) 2015-08-14
ES2349976B1 (es) 2011-11-10
EP2431046B1 (en) 2015-02-18
MX2011011970A (es) 2012-07-17
BRPI1007728A8 (pt) 2018-06-12
US20120141435A1 (en) 2012-06-07
ES2535758T3 (es) 2015-05-14
BRPI1007728A2 (pt) 2016-12-27
BRPI1007728B1 (pt) 2021-06-08
DK2431046T3 (en) 2015-05-11

Similar Documents

Publication Publication Date Title
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
ZA201107699B (en) Stable pharmaceutical composition and methods of using same
PL2473528T3 (pl) Stabilne formulacje polipeptydów i ich zastosowanie
ZA201200239B (en) Derivative of glp-1 analogue or its pharmaceutical salts and their use
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
ZA201201727B (en) Indenone derivative and pharmaceutical composition comprising same
SI2229940T1 (sl) Farmacevtski sestavek s protivnetnimi in antihistaminskimi lastnostmi
GB201108383D0 (en) Improvements in and relating to pharmaceutical compositions
ZA201108458B (en) Nitrile derivatives and their pharmaceutical use and compositions
PL2431046T3 (pl) Zastosowanie ekstraktów z liścia oliwnego w farmaceutycznej kompozycji do indukcji angiogenezy i waskulogenezy
GB0917086D0 (en) Compositon of botanical extracts and their use
IL219018A (en) Radzolid Pharmaceuticals and Uses
IL216529A0 (en) Pharmaceutical compositions comprising extracts of s arcopoterium spinosum, components thereof, and uses thereof
IL217137A0 (en) Medicinal and herbal composition and uses thereof
SK5893Y9 (sk) Bylinný prípravok na báze konope a extrakt bylinného prípravku
PL390701A1 (pl) Naturalny preparat farmaceutyczno-kosmetyczny
GB0909354D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy